Photo from wikipedia
PM: no relevant financial relationships to disclose; CH: has provided consultancy and served on a speakers bureau for Bayer, Pfizer, Shire, a Takeda company, Sobi, Biogen, CAF-DCF, CSL Behring, LFB,… Click to show full abstract
PM: no relevant financial relationships to disclose; CH: has provided consultancy and served on a speakers bureau for Bayer, Pfizer, Shire, a Takeda company, Sobi, Biogen, CAF-DCF, CSL Behring, LFB, Novo Nordisk, Roche and Octapharma, has served on a speakers bureau for Kedrion, and has received research funding from Bayer, Pfizer, Shire, a Takeda company and Sobi; TB: employee of HCD Economics and the University of Chester, and has provided consultancy for F. Hoffmann-La Roche Ltd; SA: employee of HCD Economics; FN: employee of F. Hoffmann-La Roche Ltd, has provided consultancy for Actelion, and has received research funding from Novartis and GSK; HD: employee of HCD Economics and has received research funding from F. Hoffmann-La Roche Ltd; MA and OM: employees of and holders of stock in F. Hoffmann-La Roche Ltd; JO: employee of and holder of stocks in HCD Economics, and has provided consultancy for F. Hoffmann-La Roche Ltd. Acknowledgments
Journal Title: Blood
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!